Adjunctive Treatment for Decreasing Symptoms of Schizophrenia
Status:
Completed
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
This study will determine the effectiveness of treatment with glycine or d-cycloserine in
addition to a normal antipsychotic regimen in improving negative symptoms and cognitive
impairments in patients with schizophrenia.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore
Collaborators:
Nathan Kline Institute for Psychiatric Research National Institute of Mental Health (NIMH) Sarah Herzog Hospital The Zucker Hillside Hospital University of California, Los Angeles University of Maryland, College Park